ANNUAL REPORT
Idogen's Historical Milestones - Idogen
Idogen AB (publ) Corp. Reg. No.
Investors Home
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Idogen AB (publ) kommenterar handelsstoppet den 25 april 2019 - Idogen
Annual Report
Idogen Year end report 3 - Idogen
Idogen handelsstoppad på Spotlight | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare
Board and Advisors | Ambulero
Idogen's Historical Milestones - Idogen
Joakim Söderström - Idogen
Idogen - Times Square - Idogen
Biostock intervjuar Idogens VD Anders Karlsson om kvartalsrapport Q4 samt företrädesemissionen - IPO.se
Idogen publishes Year-end report for 2020
Crown Princess and Prince Daniel visited Idogen - Idogen
Idogen extends the project portfolio to projects in autoimmune diseases - Idogen
Idogen files patent application for new tolerogenic cell therapy
Idogen AB (publ) Corp. Reg. No.
Annual Report
niklas wallett - Idogen
Idogen's cell technology successfully advanced to large-scale production - Idogen
Idogen's Historical Milestones - Idogen
Idogen AB Interim report
